Beckman Coulter to Market New Reagent for Metabolic Disease Screening.Tokyo, Japan, Mar 16, 2006 - (JCN JCN Japan Corporate News JCN Journal of Cognitive Neuroscience JCN Journal of Cardiovascular Nursing JCN Journal of Christian Nursing JCN Job Control Number JCN Journal of Child Neurology JCN joint communications network (US DoD) ) - Beckman Coulter recently announced that it will launch Access DHEA-S DHEA-S Dehydroepiandrosterone Sulfate , a measuring reagent designed for its proprietary analyzers Access Immunoassay Analyzer and UniCel Dx1 800 Immunoassay System, on March 27. Using the new reagent, analyzers are able to measure denhydroepiandrosterone sulfate sulfate, chemical compound containing the sulfate (SO4) radical. Sulfates are salts or esters of sulfuric acid, H2SO4, formed by replacing one or both of the hydrogens with a metal (e.g., sodium) or a radical (e.g., ammonium or ethyl). (DHEA-S) in samples and deliver results in 29 minutes. DHEA-S is a kind of steroid hormone which serves as an indicator of adrenal adrenal /ad·re·nal/ (ah-dre´n'l) 1. paranephric. 2. adrenal gland. 3. pertaining to an adrenal gland. ad·re·nal adj. 1. cancer and Cushing's syndrome, as well as metabolic diseases. The product comes in two packages, Access DHEA-S Reagent packs (2x50 test) and calibrators (6 vials of 2mL/vial). Copyright [c] 2006 Japan Corporate News Network. All rights reserved. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion